Literature DB >> 29617750

Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.

Levente Parragi1, N Fournier2, Jonas Zeitz1, Michael Scharl1, Thomas Greuter1, Philipp Schreiner1, Benjamin Misselwitz1, Ekaterina Safroneeva3, A M Schoepfer4, Stephan R Vavricka5, Gerhard Rogler1, Luc Biedermann1.   

Abstract

OBJECTIVES: Previous population-based studies in patients with ulcerative colitis [UC] revealed variable colectomy rates and colectomy-associated risk factors. Over the past two decades, a decrease in colectomy rates was observed. We assessed risk factors and colectomy rates over time in UC in the Swiss Inflammatory Bowel Disease Cohort Study [SIBDCS].
METHODS: Prospectively collected SIBDCS data, including disease history, baseline characteristics at enrolment, and course of disease, were retrospectively analysed. Cumulative and adjusted annual colectomy rates were calculated.
RESULTS: Among 1245 UC patients analysed [54.6% male], 114 [9.2%] underwent colectomy. We observed 5-, 10-, 15-, and 20-year cumulative colectomy rates after diagnosis of 4.1%, 6.4%, 10.4%, and 14.4% of patients, respectively. Male sex (odds ratio [OR] 1.54; p = 0.035), pancolitis at diagnosis [OR = 2.16; p = 0.005], younger age at diagnosis [OR 0.89 per 5 years of age; p = 0.006] and presence of extraintestinal manifestations [EIM] [OR 2.30; p < 0.001] were risk factors for undergoing colectomy. We did not observe a significant protective effect of smoking on colectomy risk [OR 0.64; p = 0.106]. The majority of colectomies were performed within first 10 years of disease onset, with a rapidly decreasing colectomy rate after 15 years. In patients diagnosed after 2003, colectomy was performed much earlier during and individual's disease course. Nevertheless, we found a significantly decreasing trend in yearly colectomy rates over time after 2005.
CONCLUSIONS: Crude and adjusted colectomy rates in Swiss UC patients were lower than those reported previously in the literature, and decreased over time.

Entities:  

Mesh:

Year:  2018        PMID: 29617750     DOI: 10.1093/ecco-jcc/jjy040

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  26 in total

1.  Trends in Colectomies for Colorectal Neoplasms in Ulcerative Colitis: a National Inpatient Sample Database Analysis over Two Decades.

Authors:  Alexander Ni; Mohammed Al-Qahtani; Ebram Salama; Daniel Marinescu; Maria Abou Khalil; Julio Faria; Nancy Morin; Gabriela Ghitulescu; Carol-Ann Vasilevsky; Marylise Boutros
Journal:  J Gastrointest Surg       Date:  2020-06-15       Impact factor: 3.452

2.  Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative Colitis.

Authors:  Nghia H Nguyen; Soumya Kurnool; Parambir S Dulai; Brigid S Boland; William J Sandborn; Siddharth Singh
Journal:  Inflamm Bowel Dis       Date:  2020-08-20       Impact factor: 5.325

3.  Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis.

Authors:  Edward L Barnes; Yue Jiang; Michael D Kappelman; Millie D Long; Robert S Sandler; Alan C Kinlaw; Hans H Herfarth
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 5.325

4.  Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample study.

Authors:  Maia Kayal; Aparna Saha; Priti Poojary; Sudarshan Paramsothy; Robert Hirten; Louis Cohen; Zane Gallinger; Saurabh Mehandru; Judy Cho; Alexander Greenstein; Girish Nadkarni; Marla C Dubinsky; Jean-Frederic Colombel; Benjamin Cohen; Ryan Ungaro
Journal:  Int J Colorectal Dis       Date:  2019-09-11       Impact factor: 2.571

5.  Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy Rates.

Authors:  Alice C Moore; Brian Bressler
Journal:  Dig Dis Sci       Date:  2019-05-15       Impact factor: 3.199

6.  Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control?

Authors:  Hassan Ghoz; Alex Kesler; Sanne A Hoogenboom; Filippo Gavi; Bhaumik Brahmbhatt; John Cangemi; Paul T Kröner
Journal:  J Gastrointest Surg       Date:  2019-12-03       Impact factor: 3.452

Review 7.  Pouchitis: Treatment dilemmas at different stages of the disease.

Authors:  Manuel Barreiro-de Acosta; Iria Bastón-Rey; Cristina Calviño-Suárez; J Enrique Domínguez-Muñoz
Journal:  United European Gastroenterol J       Date:  2020-01-13       Impact factor: 4.623

8.  Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis.

Authors:  Thomas Ochsenkühn; Cornelia Tillack; Daniel Szokodi; Shorena Janelidze; Fabian Schnitzler
Journal:  United European Gastroenterol J       Date:  2019-12-12       Impact factor: 4.623

Review 9.  WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting.

Authors:  Belinda De Simone; Justin Davies; Elie Chouillard; Salomone Di Saverio; Frank Hoentjen; Antonio Tarasconi; Massimo Sartelli; Walter L Biffl; Luca Ansaloni; Federico Coccolini; Massimo Chiarugi; Nicola De'Angelis; Ernest E Moore; Yoram Kluger; Fikri Abu-Zidan; Boris Sakakushev; Raul Coimbra; Valerio Celentano; Imtiaz Wani; Tadeja Pintar; Gabriele Sganga; Isidoro Di Carlo; Dario Tartaglia; Manos Pikoulis; Maurizio Cardi; Marc A De Moya; Ari Leppaniemi; Andrew Kirkpatrick; Vanni Agnoletti; Gilberto Poggioli; Paolo Carcoforo; Gian Luca Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-05-11       Impact factor: 5.469

Review 10.  Medical Therapy in Chronic Refractory Ulcerative Colitis: When Enough Is Enough.

Authors:  Aderson Omar Mourão Cintra Damião; Natália Sousa Freitas Queiroz
Journal:  Clin Colon Rectal Surg       Date:  2022-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.